Abstract
44P Exploratory analysis of peripheral pharmacodynamic (PD) biomarkers after sitravatinib (Sitra) and tislelizumab (TIS) in advanced solid tumors: SAFFRON-103
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have